Citation Impact
Citing Papers
Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry
2012
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
2017 Standout
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
2009 StandoutNobel
Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy
2007
Common Transcriptional Signature of Tumor-Infiltrating Mononuclear Inflammatory Cells and Peripheral Blood Mononuclear Cells in Hepatocellular Carcinoma Patients
2008
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
2009 StandoutNobel
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma†
2008
Laparoscopic versus open liver resection for hepatocellular carcinoma: Case-matched study with propensity score matching
2015
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
2010
Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials
2009
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Meta-Analysis of Trials Comparing Minimally-Invasive and Open Liver Resections for Hepatocellular Carcinoma
2011
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer
2012
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Comparative Short-term Benefits of Laparoscopic Liver Resection
2015
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Laparoscopicvsopen approach to resection of hepatocellular carcinoma in patients with known cirrhosis: Systematic review and meta-analysis
2014
Combination of Conformal Radiotherapy and Intratumoral Injection of Adoptive Dendritic Cell Immunotherapy in Refractory Hepatoma
2005
Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma
2015
Identification and analysis of tumour-associated antigens in hepatocellular carcinoma
2005
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Hepatocellular Carcinoma
2011
Shank-interacting protein–like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells
2010
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
CD39 and CD73 in immunity and inflammation
2013 Standout
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults
2017
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Renal cell carcinoma
2017 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Hepatocellular carcinoma
2022 Standout
Antitumor effects of the MIG and IP-10 genes transferred with poly [D,L-2,4-diaminobutyric acid] on murine neuroblastoma
2007
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Modulation of Cancer-Specific Immune Responses by Amino Acid Degrading Enzymes
2016
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
Role of indoleamine 2,3-dioxygenase in health and disease
2015
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses
2011 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
2012
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
2014
The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function
2006
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
2018 Standout
Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon Adenocarcinoma
2009
Blockade of IDO Inhibits Nasal Tolerance Induction
2007
Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer
2009
A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides
2006
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease
2015
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma
2016
Works of Seiichiro Kai being referenced
A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
2003
Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma
2004
Short- and Long-Term Outcomes after Hepatic Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices in Patients with Cirrhosis
2008
A Comparative Study of the Long-term Outcomes After Laparoscopy-assisted and Open Left Lateral Hepatectomy for Hepatocellular Carcinoma
2009
Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor‐infiltrating lymphocytes
2006
Prognostic Value of Preoperative Peripheral Blood Monocyte Count in Patients with Colorectal Liver Metastasis after Liver Resection
2007
A small interfering RNA targeting proteinase‐activated receptor‐2 is effective in suppression of tumor growth in a Panc1 xenograft model
2007
Inhibition of indoleamine 2,3‐dioxygenase suppresses NK cell activity and accelerates tumor growth
2003
Initial J apanese experience with the LAP ‐BAND system
2012